CompletedNot Applicable

MYometrial Lesion UltrasouNd And mRi

Italy2,353 participantsStarted 2019-01-17

Plain-language summary

A monocentric prospective observational study aimed at assessing the accuracy of a diagnostic algorithm to pre-operatively identify uterine sarcomas.. Primary Aim:The primary outcome is to evaluate the accuracy (sensitivity/specificity) of "Positive Orange Criteria" category in predicting uterine sarcoma and STUMP in the population of patients with \> 3 cm myometrial lesions.

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Consecutive patients admitted to our Department for transvaginal ultrasound examination, in whom a myometrial lesion \> 3cm in size is detected. * Informed consent form signed by the patient. Exclusion Criteria: * Patients undergoing medical treatment for myometrial lesion; * Patients previously treated with hormonal therapy including estroprogestin in the last six months; * Patients previously treated by embolization

What they're measuring

Diagnostic algorithm in predicting uterine sarcoma and STUMP

Timeframe: January 2019- January 2024

Trial details

NCT IDNCT04123158

SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12-04

View on ClinicalTrials.gov More Sarcoma Uterus trials